E for L Aim Public Company Limited (EFORL) - Net Assets

Latest as of June 2026: ฿592.96 Million THB ≈ $18.48 Million USD

Based on the latest financial reports, E for L Aim Public Company Limited (EFORL) has net assets worth ฿592.96 Million THB (≈ $18.48 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (฿1.14 Billion ≈ $35.38 Million USD) and total liabilities (฿542.20 Million ≈ $16.90 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check EFORL strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric Value
Current Net Assets ฿592.96 Million
% of Total Assets 52.24%
Annual Growth Rate 7.21%
5-Year Change 48.45%
10-Year Change -70.66%
Growth Volatility 537.19

E for L Aim Public Company Limited - Net Assets Trend (2007–2025)

This chart illustrates how E for L Aim Public Company Limited's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see E for L Aim Public Company Limited market capitalisation.

Annual Net Assets for E for L Aim Public Company Limited (2007–2025)

The table below shows the annual net assets of E for L Aim Public Company Limited from 2007 to 2025. Also explore E for L Aim Public Company Limited annual equity growth to track the company's year-over-year net asset growth rate.

Year Net Assets Change
2025-12-31 ฿583.26 Million
≈ $18.18 Million
+7.16%
2024-12-31 ฿544.31 Million
≈ $16.97 Million
+3.75%
2023-12-31 ฿524.62 Million
≈ $16.35 Million
+3.59%
2022-12-31 ฿506.42 Million
≈ $15.78 Million
+28.90%
2021-12-31 ฿392.89 Million
≈ $12.25 Million
+152.98%
2020-12-31 ฿-741.64 Million
≈ $-23.12 Million
-609.20%
2019-12-31 ฿-104.57 Million
≈ $-3.26 Million
-137.79%
2018-12-31 ฿276.72 Million
≈ $8.63 Million
+389.56%
2017-12-31 ฿-95.56 Million
≈ $-2.98 Million
-104.81%
2016-12-31 ฿1.99 Billion
≈ $61.97 Million
-33.69%
2015-12-31 ฿3.00 Billion
≈ $93.45 Million
+53.81%
2014-12-31 ฿1.95 Billion
≈ $60.76 Million
+179.35%
2013-12-31 ฿697.78 Million
≈ $21.75 Million
+2127.96%
2012-12-31 ฿31.32 Million
≈ $976.19K
-67.63%
2011-12-31 ฿96.75 Million
≈ $3.02 Million
-34.94%
2010-12-31 ฿148.70 Million
≈ $4.63 Million
-45.57%
2009-12-31 ฿273.21 Million
≈ $8.52 Million
+2.72%
2008-12-31 ฿265.97 Million
≈ $8.29 Million
+59.71%
2007-12-31 ฿166.53 Million
≈ $5.19 Million
--

Equity Component Analysis

This analysis shows how different components contribute to E for L Aim Public Company Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 12314.5% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Common Stock ฿3.00 Billion 514.16%
Other Comprehensive Income ฿37.00 Million 6.34%
Total Equity ฿583.26 Million 100.00%

E for L Aim Public Company Limited Competitors by Market Cap

The table below lists competitors of E for L Aim Public Company Limited ranked by their market capitalization.

Company Market Cap
Big Pharma Split Corp Class A
TO:PRM
$13.71 Million
Skillful Craftsman Education Tech
NASDAQ:EDTK
$13.72 Million
Lifecare AS
OL:LIFE
$13.73 Million
GMV Minerals Inc
V:GMV
$13.74 Million
Unimit Engineering Public Company Limited
BK:UEC
$13.69 Million
Dgenx Co. Ltd
KQ:113810
$13.69 Million
Kordsa Global Endustriyel Iplik ve Kord Bezi Sanayi ve Ticaret AS
IS:KORDS
$13.68 Million
Burcon NutraScience Corporation
TO:BU
$13.68 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in E for L Aim Public Company Limited's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 544,312,000 to 583,258,000, a change of 38,946,000 (7.2%).
  • Net income of 44,573,000 contributed positively to equity growth.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income ฿44.57 Million +7.64%
Other Changes ฿-5.63 Million -0.96%
Total Change ฿- 7.16%

Book Value vs Market Value Analysis

This analysis compares E for L Aim Public Company Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.75x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has increased from 0.09x to 0.75x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2007-12-31 ฿1.18 ฿0.11 x
2008-12-31 ฿1.39 ฿0.11 x
2009-12-31 ฿0.98 ฿0.11 x
2010-12-31 ฿0.53 ฿0.11 x
2011-12-31 ฿0.35 ฿0.11 x
2012-12-31 ฿0.11 ฿0.11 x
2013-12-31 ฿1.16 ฿0.11 x
2014-12-31 ฿0.70 ฿0.11 x
2015-12-31 ฿1.42 ฿0.11 x
2016-12-31 ฿0.90 ฿0.11 x
2017-12-31 ฿0.09 ฿0.11 x
2018-12-31 ฿0.14 ฿0.11 x
2019-12-31 ฿0.10 ฿0.11 x
2020-12-31 ฿0.23 ฿0.11 x
2021-12-31 ฿0.11 ฿0.11 x
2022-12-31 ฿0.13 ฿0.11 x
2023-12-31 ฿0.13 ฿0.11 x
2024-12-31 ฿0.14 ฿0.11 x
2025-12-31 ฿0.15 ฿0.11 x

Capital Efficiency Dashboard

This dashboard shows how efficiently E for L Aim Public Company Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 7.64%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 3.41%
  • • Asset Turnover: 1.04x
  • • Equity Multiplier: 2.15x
  • Recent ROE (7.64%) is above the historical average (-69.03%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2007 14.03% 17.21% 0.57x 1.43x ฿6.72 Million
2008 18.59% 22.44% 0.70x 1.18x ฿22.84 Million
2009 -20.12% -27.53% 0.64x 1.15x ฿-82.28 Million
2010 -83.73% -80.13% 0.81x 1.29x ฿-139.38 Million
2011 -52.98% -26.61% 1.20x 1.66x ฿-60.93 Million
2012 -208.91% -75.03% 1.43x 1.94x ฿-68.56 Million
2013 3.79% 15.49% 0.20x 1.21x ฿-43.32 Million
2014 25.65% 16.60% 0.20x 7.85x ฿146.88 Million
2015 16.12% 4.67% 0.62x 5.60x ฿79.88 Million
2016 -63.82% -16.73% 0.54x 7.01x ฿-710.72 Million
2017 -885.07% -47.02% 0.64x 29.57x ฿-1.18 Billion
2018 -37.59% -8.07% 0.64x 7.27x ฿-210.55 Million
2019 -182.20% -30.74% 0.79x 7.54x ฿-623.00 Million
2020 -86.31% -38.01% 1.07x 2.12x ฿-706.92 Million
2021 206.68% 37.50% 1.29x 4.27x ฿772.74 Million
2022 10.47% 3.55% 0.97x 3.05x ฿2.40 Million
2023 2.56% 1.03% 0.96x 2.61x ฿-39.03 Million
2024 3.62% 1.47% 0.95x 2.58x ฿-34.74 Million
2025 7.64% 3.41% 1.04x 2.15x ฿-13.75 Million

Industry Comparison

This section compares E for L Aim Public Company Limited's net assets metrics with peer companies in the Medical Distribution industry.

Industry Context

  • Industry: Medical Distribution
  • Average net assets among peers: $356,573,760
  • Average return on equity (ROE) among peers: 7.55%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
E for L Aim Public Company Limited (EFORL) ฿592.96 Million 14.03% 0.91x $13.71 Million
Techno Medical Public Company Limited (TM) $356.57 Million 7.55% 0.97x $12.48 Million

About E for L Aim Public Company Limited

BK:EFORL Thailand Medical Distribution
Market Cap
$13.71 Million
฿439.83 Million THB
Market Cap Rank
#26342 Global
#537 in Thailand
Share Price
฿0.11
Change (1 day)
+0.00%
52-Week Range
฿0.10 - ฿0.20
All Time High
฿11.35
About

E for L Aim Public Company Limited, together with its subsidiaries, engages in the distribution of medical devices and equipment in Thailand, the United States, Europe, and Asia. The company offers medical devices, including patient and central monitor systems, defibrillator, automated external defibrillator, electrocardiographs, electroencephalogram, PSG system, and accessories and consumables, … Read more